戻る
NovaBay Pharmaceuticals Inc (NBY)価格
NBY 株価推移チャート
NBY 収入
NovaBay Pharmaceuticals Inc
$14.77
16.39%
$2.08
終値： Jan 16, 16:00:00 GMT-5
$12.56
-14.96%
$-2.2
プレマーケット： Jan 20, 05:13:42 GMT-5
主要データ
前終値
$12.69
始値
$12.3
当日レンジ
$11.91 - $18.4
52週レンジ
$0.46 - $19.95
取引高
2.7M
平均取引高
1.2M
1株当たり利益(TTM)
-6.62
配当利回り
--
時価総額
$1.5B
NBYとは何ですか？
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.